Integral Diagnostics Limited (ASX:IDX)
2.440
+0.030 (1.24%)
Feb 26, 2026, 2:19 PM AEST
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 897.36 million as of February 25, 2026. Its market cap has decreased by -18.73% in one year.
Market Cap
897.36M
Enterprise Value
1.47B
Revenue
767.82M
Ranking
n/a
PE Ratio
64.24
Stock Price
2.44
Market Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 897.36M, an increase of 240.21%. That is a compound annual growth rate of 12.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 897.36M | -5.21% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 11.43B |
| Healius | 490.14M |
| Australian Clinical Labs | 416.02M |
| Monash IVF Group | 268.85M |
| Rhythm Biosciences | 73.67M |
| Cryosite | 58.57M |
| Microba Life Sciences | 51.76M |
| INOVIQ | 48.57M |